CSBR:NASDAQ
Champions Oncology Inc
4,70 USD
arrow_upward
+1,18%(+0,055) 1 D
13. nov., 16:00:00 GMT-5 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for CSBR …
Åpne
4,57 USD
Høy
4,70 USD
Lav
4,52 USD
Markedsverdi
65,49 mill.
Snittvolum
8,16k
Volum
0,00
52 u høy
8,31 USD
52 u lav
4,52 USD
EPS
−0,08 USD
Beta
0,47
Utestående aksjer
13,92 mill.
Antall ansatte
217
Åpne
4,57 USD
Høy
4,70 USD
Lav
4,52 USD
Markedsverdi
65,49 mill.
Snittvolum
8,16k
Volum
0,00
52 u høy
8,31 USD
52 u lav
4,52 USD
EPS
−0,08 USD
Beta
0,47
Utestående aksjer
13,92 mill.
Antall ansatte
217
Nyhetssaker
Fra nettkilder og nyhetspartnere
Dagens Næringsliv
·
for 11 timer siden
Morgan Stanley med superoptimistisk aksjespådom
Quantisnow
·
for 21 minutter siden
SCIENTURE Reports Q3 2026 Results with Approximately 265%...
ChartMill
·
for 23 minutter siden
Premarket Movers on Nov. 16, 2026: Gainers and Decliners
Dealroom
·
for 18 minutter siden
Enlivex raises $7.5M in staggered share offering priced above market
Profil
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
Om Champions Oncology Inc
Administrerende direktør-
Ansatte217
Grunnlagt2007
HovedkontorHackensack, New Jersey, USA
SektorHealth Care
Bransje-
Nettstedchampionsoncology.com